foxo4-dri senolytic mouse 2023 2024

foxo4-dri senolytic mouse 2023 2024 Frontiers The disordered p53 transactivation domain

Name: foxo4-dri senolytic mouse 2023 2024 Frontiers The disordered p53 transactivation domain
Brand: webdevsolutions.tech
SKU: 43274943843
Price: 20.96 USD
Availability: InStock
Rating: 4.7686 (16 reviews)

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine

SKU: 43274943843 · From webdevsolutions.tech

4.8

USD20.96 USD52.96

Pay in 4 interest-free payments of $5.24 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 17 - Aug 22

Description

That said, the human evidence for each pathway remains preliminary

In preclinical studies, it inhibited proliferation of a broad range of tumor cell lines (cell IC50 6.2 nM to 4.3 M) and inhibited HUVEC growth in response to HGF and VEGF as an in vitro model of angiogenesis [116]

Although interest is growing, it is important to understand that BPC-157 is still being researched, and use should only occur under the guidance of a qualified medical provider